Skip to main content

Jared Gollob

Equibles does not estimate personal net worth.

About Jared Gollob

The proxy statement of Kymera Therapeutics, Inc. reports total compensation of $2,914,330 for Jared Gollob in fiscal 2025, including a base salary of $507,100. Disclosed compensation is on record for 7 fiscal years. Jared Gollob has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Kymera Therapeutics, Inc. on August 5, 2026. The companies whose calls Jared Gollob spoke on are classified in the Healthcare sector.

Jared Gollob on recent calls

“While it's certainly bittersweet to say goodbye, I have made the decision to retire after having spent 20 years in academic medicine, followed by 20 years in industry, including the last eight years at Chimera.”
Board Member, Kymera Therapeutics, Inc. Q2 FY2026 Earnings Call ·
“Yeah, I think in terms of, say, small molecule inhibitors, for example, of STAS-6 versus degraders, we think that there is significant differentiation because the pharmacology of degraders allow us to degrade STAS-6 completely and keep it down 24-7, which is really the sort of inhibition you need if you want to…”
Other, Bank of America 2026 Healthcare Conference ·
“As you've heard, we're building significant momentum across our pipeline, driven by the strong scientific, clinical, and operational foundation that we've established.”
Other, Kymera Therapeutics, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Kymera Therapeutics, Inc. (KYMR) $507,100 $2,914,330
2024 Kymera Therapeutics, Inc. (KYMR) $490,000 $5,749,693
2023 Kymera Therapeutics, Inc. (KYMR) $480,000 $3,474,154
2022 Kymera Therapeutics, Inc. (KYMR) $460,006 $2,765,015
2021 Kymera Therapeutics, Inc. (KYMR) $432,635 $3,500,801
2020 Kymera Therapeutics, Inc. (KYMR) $383,210 $1,452,716
2019 Kymera Therapeutics, Inc. (KYMR) $344,908 $688,199

Recent activity